期刊文献+

COPD所致肺动脉高压与同型半胱氨酸相关性研究 被引量:3

Study on the Correlation between Homocysteine and Pulmonary Hypertension(PH) Induced by Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:探讨慢性阻塞性肺疾病(COPD)所致不同程度肺动脉高压(PH)与血浆同型半胱氨酸(Hcy)的相关性。方法:应用反相高效液相色谱荧光检测法测定了COPD合并PH轻、中、重度患者以及COPD合并高血压及PH轻、中、重度患者的Hcy,采用SPSS 17.0软件对数据进行统计分析。结果:COPD合并PH轻、中、重度患者血浆Hcy差异无统计学意义(P>0.05),但COPD合并PH及高血压患者的Hcy明显高于未合并高血压患者(P<0.05)。结论:检测血浆Hcy对于高血压疾病的预防、诊断具有重要的临床应用价值,但对于COPD合并PH疾病无太大的临床应用价值。 Objective: To investigate the correlation between plasma homocysteine(Hcy) and pulmonary hypertension(PH) induced by chronic obstructive pulmonary disease(COPD).Method: Hcy was determined by RP-HPLC in the patients with COPD and PH at the level of light,moderate and severe and the patients with hypertension induced by COPD and PH at the level of light,moderate and severe.The data were analyzed by SPSS 17.0 statistical software.Result: The content of plasma Hcy showed no statistical difference in the patients with COPD and PH(P0.05),while that in the patients with hypertension induced by COPD and PH was much higher(P0.05).Conclusion: It is important to detect plasma Hcy in preventing and diagnosing hypertensive diseases,while it is less valuable in the patients with COPD and PH.
出处 《中国药师》 CAS 2012年第10期1475-1476,共2页 China Pharmacist
基金 云南省教育厅科学研究基金(编号:2010Y171)
关键词 慢性阻塞性肺疾病 肺动脉高压 同型半胱氨酸 Chronic obstructive pulmonary disease Pulmonary hypertension Homocysteine
  • 相关文献

参考文献4

二级参考文献52

共引文献8249

同被引文献42

  • 1张建全,钟小宁,蒋明,柳广南.慢支、肺气肿并肺动脉高压的特征及其机制探讨[J].广西医科大学学报,2006,23(3):375-378. 被引量:13
  • 2Maclay J D, McAllister D A, Mills N L, et al. Vascular dys- function in chronic obstructive pulmonary disease [ J ]. Am J Respir Crit Care Med, 2009, 180(6): 513.
  • 3Tsemakh I Ia, Momot A P, Kostiuehenko G I, et al. Role of endothelial dysfunction, the interface between hemostatic and system inflammatory responses in the pathogenesis of an infectious inflammation-dependent exacerbation of chronic ob- structive pulmonary disease [ J ]. Ter Arkh, 2013, 85 ( 3 ) : 17.
  • 4Fimognari F L, Loffredo L, Di Simone S, et al. Hyperho- moeysteinaemia and poor vitamin B status in chronic obstruc- tive pulmonary disease [ J ]. Nutr Metab Cardiovasc Dis, 2009, 19(9): 654.
  • 5Seemungal T A, Lun J C, Davis G, et al. Plasma homocys- teine is elevated in COPD patients and is related to COPD severity[J]. Int J Chron Obstruct Pulmon Dis, 2007, 2(3) : 313.
  • 6Duvoix A, Dickens J, Haq I, et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease[J ]. Tho- rax, 2013, 68(7): 670.
  • 7Fijadkowska A, Wiatr E, Kurzyna M, et al. Normal D- dimer concentration in hospitalized patients with lung diseases [J]. Pneumonol Alergol Pol, 2012, 80(2) : 101.
  • 8CLARKE R,STANSBIE D. Assessment of homocysteine as a cardiovas- cular risk factor in clinical practice [ J]. Ann Clin Biochem, 2001,38 (6) :624 -632.
  • 9Morrell NW,Danto S,Archer SL, et al. Cellular and molecular basis of pulmonary arterial hypertension [ J ]. Am Cull Cordial, 2009,54 ( 1S ) : $20 - $31.
  • 10Galie N, Hoeper MM, Humbert M, et at. Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diag- nosis and Treatment of Pulmonary Hypertension of the European Socie- ty of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [ J 1. Eur Heart J, 2009, 30 ( 20 ) : 2493 - 2537.

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部